Pharmacokinetic, Efficacy and Safety of BT524 in Patients With Congenital Fibrinogen Deficiency

Conditions:   Congenital Afibrinogenemia;   Congenital HypofibrinogenemiaIntervention:   Biological: BT524 (fibrinogen concentrate from human plasma)Sponsors:   Biotest;   Aptiv Solutions;   Interlab;   Phoenix Clinical ResearchRecruiting - verified February 2014

Source: ClinicalTrials.gov - February 3, 2014 Category: Research Source Type: clinical trials